Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Synairgen Share Price
  4. Synairgen Share Regulatory News
  5. Appointment of Joint Broker

Pin to quick picksSynairgen Regulatory News (SNG)

Synairgen Information

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.48 (26.812%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.20
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Joint Broker

2 Oct 2020 07:00

RNS Number : 8826A
Synairgen plc
02 October 2020
 

Synairgen plc

 

('Synairgen' or the 'Company')

 

Appointment of Joint Broker

 

Southampton, UK - 2 October 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, is pleased to announce the appointment of Numis Securities Limited as Joint Broker to the Company with immediate effect. finnCap remains Nominated Adviser and Joint Broker to the Company.

-Ends

 

For further enquiries, please contact:

 

Synairgen plc

Richard Marsden, Chief Executive Officer

John Ward, Finance Director

Tel: + 44 (0) 23 8051 2800

 

finnCap (Nominated Advisor & Joint Broker)

Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance)

Alice Lane, Manasa Patil (ECM)

Tel: + 44 (0) 20 7220 0500

 

Numis Securities Limited (Joint Broker)

James Black, Freddie Barnfield

Tel: +44 (0) 20 7260 1000

 

Consilium Strategic Communications (Financial Media & Investor Relations)

Mary-Jane Elliott, Sue Stuart, Olivia Manser

synairgen@consilium-comms.com

Tel: +44 (0) 20 3709 5700

 

Notes for Editors

 

About Synairgen

Synairgen is a respiratory drug discovery and development company founded by University of

Southampton Professors Stephen Holgate, Donna Davies, and Ratko Djukanovic. The

business, focused primarily on lung viral defence in asthma, COPD, and COVID-19, uses its

differentiating human biology BioBank platform and world-renowned international academic

KOL network to discover and develop novel therapies for respiratory disease. Synairgen is

quoted on AIM (LSE: SNG). For more information about Synairgen, please see

https://www.synairgen.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPUASBRRSURRAA
12345678910
Date   Source Headline
25th Jan 20217:00 amRNSInclusion in US ACTIV-2 trial
20th Jan 20217:00 amRNSHome trial recruitment completed
13th Jan 20217:00 amRNSFirst Patient Dosing in Phase III SG018 Trial
6th Jan 20215:10 pmRNSHolding(s) in Company
5th Jan 20215:53 pmRNSHolding(s) in Company
18th Dec 20207:00 amRNSCOVID-19 Clinical Programme Update
10th Dec 202012:57 pmRNSHolding(s) in Company
13th Nov 20205:03 pmRNSHolding(s) in Company
13th Nov 20207:00 amRNSLancet Respiratory Medicine publishes Phase 2 data
10th Nov 20201:47 pmRNSHolding(s) in Company
4th Nov 20205:51 pmRNSHolding(s) in Company
3rd Nov 20209:00 amRNSHolding(s) in Company
2nd Nov 202012:20 pmRNSResult of General Meeting and Total Voting Rights
2nd Nov 20207:00 amRNSResult of Open Offer
28th Oct 202011:20 amRNSHolding(s) in Company
27th Oct 20208:35 amRNSHolding(s) in Company
21st Oct 20209:45 amRNSHolding(s) in Company
21st Oct 20209:40 amRNSHolding(s) in Company
16th Oct 20203:10 pmRNSExercise of Options and Total Voting Rights
15th Oct 20205:35 pmRNSExercise of Options and Total Voting Rights
15th Oct 20201:51 pmRNSDirector/PDMR Shareholding
15th Oct 20207:00 amRNSResults of Placing
14th Oct 20205:32 pmRNSPlacing and Open Offer
12th Oct 202011:05 amRNSSecond Price Monitoring Extn
12th Oct 202011:00 amRNSPrice Monitoring Extension
6th Oct 20208:55 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSAppointment of Joint Broker
1st Oct 20202:06 pmRNSSecond Price Monitoring Extn
1st Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 202011:00 amRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSClinigen signs MAP agreement with Synairgen
29th Sep 20207:00 amRNSSynairgen and Clinigen sign Managed Access Program
29th Sep 20207:00 amRNSInterim results for six months ended 30 June 2020
9th Sep 20207:00 amRNSSynairgen IP Update
8th Sep 20207:00 amRNSPositive interim analysis of SNG001 in COPD
7th Sep 20203:53 pmRNSHolding(s) in Company
3rd Sep 20205:58 pmRNSHolding(s) in Company
1st Sep 20204:41 pmRNSSecond Price Monitoring Extn
1st Sep 20204:36 pmRNSPrice Monitoring Extension
24th Aug 20204:41 pmRNSSecond Price Monitoring Extn
24th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 20205:28 pmRNSHolding(s) in Company
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
13th Aug 20207:57 amRNSHolding(s) in Company
10th Aug 20209:50 amRNSHolding(s) in Company
7th Aug 20208:22 amRNSHolding(s) in Company
5th Aug 20205:51 pmRNSHolding(s) in Company
31st Jul 20208:37 amRNSHolding(s) in Company
29th Jul 20204:43 pmRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.